KPCB

Connect Biopharma Appoints Industry Veteran James Huang to Board of Directors

Retrieved on: 
Monday, February 12, 2024

James Huang is the Founder and Managing Partner of Panacea Venture, a significant shareholder of the Company.

Key Points: 
  • James Huang is the Founder and Managing Partner of Panacea Venture, a significant shareholder of the Company.
  • “We are thrilled to welcome James to Connect’s Board of Directors,” said Wubin (Bill) Pan, Ph.D., M.B.A., Co-Founder, President, and Chairman of the Board of Connect Biopharma.
  • “His breadth of biotech and investment experience, coupled with his passion for innovative and transformative life science companies will provide our Board with a unique perspective.
  • Additionally, Mr. Huang serves as a director on the board of directors of a number of companies, including Kindstar Global, TacTiva Therapeutics, TriArm Therapeutics, Chime Biologics, Eos, GT Aperion, Domain, Asia Pacific Medical and XWPharma.

CCV CAPITAL: Strategies for Chinese Enterprises to Breakthrough in the New Situation

Retrieved on: 
Monday, January 22, 2024

Recently, during the opening speech of the NetEase's 'Future Open Class', Wei Zhou, CCV CAPITAL's founding manager partner, delivered a keynote address on the topic 'Strategies for Chinese Enterprises to Breakthrough in the New Situation.'

Key Points: 
  • Recently, during the opening speech of the NetEase's 'Future Open Class', Wei Zhou, CCV CAPITAL's founding manager partner, delivered a keynote address on the topic 'Strategies for Chinese Enterprises to Breakthrough in the New Situation.'
  • The following is an excerpt from the speech:
    Today, the topic I want to share is "How Chinese Enterprises Breakout in the New Situation".
  • In this situation, we have done a lot of research, that in the new situation of Chinese enterprises in the breakthrough way, summarized in two directions, a theme.
  • Why is it a very appropriate time for Chinese enterprises and individuals to "Go Global" under the new situation.

CCV CAPITAL: Green Technology, Extreme Climate, Now and Future

Retrieved on: 
Monday, January 15, 2024

The CCV team, led by Wei Zhou, inherits the green technology genes from KPCB.

Key Points: 
  • The CCV team, led by Wei Zhou, inherits the green technology genes from KPCB.
  • Since its establishment in 2017, CCV has strategically invested in numerous innovative enterprises related to green technology.
  • Wei Zhou emphasized that CCV will continue to deepen its involvement in the green technology industry, expressing confidence that more Chinese entrepreneurial teams will have opportunities to go global in the field of green technology.
  • The overall direction of green technology was sound, but as a venture capital firm, we must focus on returns.

Dialogue with CCV's Wei Zhou: in Globalization 3.0 Era- ESG as the Lifeline for Expanding Businesses Globally

Retrieved on: 
Friday, November 17, 2023

Recently, EqualOcean's "Globalization Lounge" live streaming event hosted a profound discussion on the theme of "Globalization 3.0 Era: ESG as the Lifeline for Expanding Businesses Globally."

Key Points: 
  • Recently, EqualOcean's "Globalization Lounge" live streaming event hosted a profound discussion on the theme of "Globalization 3.0 Era: ESG as the Lifeline for Expanding Businesses Globally."
  • KPCB initiated green technology investments globally since the early 2000s, while the domestic surge in China started in 2007.
  • The technological maturity of the products was insufficient for full commercialization, and businesses couldn't generate enough cash flow to sustain themselves.
  • Looking ahead to 2024, what are your expectations for the integration of ESG in the globalization of Chinese companies?

Venture Capital Firm CCV Signs UNPRI, Makes a Commitment to Responsible and Sustainable Living

Retrieved on: 
Tuesday, February 28, 2023

Wei Zhou, Founding Partner of CCV, said, "It's an honor to join the UN PRI initiatives.

Key Points: 
  • Wei Zhou, Founding Partner of CCV, said, "It's an honor to join the UN PRI initiatives.
  • Some innovative technologies may seem too early from the perspective of financial return, but they are critical in terms of mankind's future development.
  • CCV's focus on responsible investment originates from KPCB China's commitment to green technology.
  • As the former core investment team at KPCB, CCV devoted numerous efforts to researching and investing in related tracks.

CCV's Portfolio Perfect Corp. and Provident Acquisition Corp. Complete Business Combination

Retrieved on: 
Tuesday, November 1, 2022

BEIJING, Oct. 31, 2022 /PRNewswire/ -- CCV's early-stage portfolio company Perfect Corp. ("Perfect"), a global leader in providing augmented reality ("AR") and artificial intelligence ("AI") Software-as-a-Service ("SaaS") solutions to beauty and fashion industries, and Provident Acquisition Corp. (Nasdaq: PAQC; "Provident"), a special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination").

Key Points: 
  • BEIJING, Oct. 31, 2022 /PRNewswire/ -- CCV's early-stage portfolio company Perfect Corp. ("Perfect"), a global leader in providing augmented reality ("AR") and artificial intelligence ("AI") Software-as-a-Service ("SaaS") solutions to beauty and fashion industries, and Provident Acquisition Corp. (Nasdaq: PAQC; "Provident"), a special purpose acquisition company, today announced the completion of their previously announced business combination (the "Business Combination").
  • The listed company resulting from the Business Combination will be called Perfect Corp, and its shares and warrants will commence trading on the New York Stock Exchange under the ticker symbols "PERF" and "PERF WS" respectively, on October 31, 2022.
  • Perfect is also the second IPO that the CCV team has harvested since Arrail Dental (HKSE:6639) was listed in Hong Kong Stock Exchange earlier this year.
  • The PIPE transaction is backed by blue-chip investors including CHANEL, CyberLink, Shiseido, and Snap as well as reputable financial investors.

CCV Managing Partner: Metaverse is about Creation

Retrieved on: 
Tuesday, August 30, 2022

BEIJING, Aug. 30, 2022 /PRNewswire/ -- Investors at China Creation Ventures (CCV), a leading venture capital fund in China, are optimistic about the future of the metaverse.

Key Points: 
  • BEIJING, Aug. 30, 2022 /PRNewswire/ -- Investors at China Creation Ventures (CCV), a leading venture capital fund in China, are optimistic about the future of the metaverse.
  • "The fundamental concept of the metaverse should be 'creation.'
  • CCV started its investment in the metaverse and digital twin technologies in 2017.
  • Its founder,Wei Zhou, is one of China's most successful venture capitalists in technology and a former managing partner at KPCB China.

CCV, one of China's leading venture capital funds, affirms support for hard tech startups and China's globally-focused entrepreneurs despite changing environment

Retrieved on: 
Monday, August 8, 2022

BEIJING, Aug. 8, 2022 /PRNewswire/ -- WeiZhou, the founder and managing partner of venture capital firm CCV, said in a recent GoldmanSachs panel that his firm would intensify its focus on deep tech in China and Chinese startups with global potential.

Key Points: 
  • Wei's prediction echoes the Chinese government's 14th Five-Year Plan (2021-2025), which made advanced manufacturing upgrades a top priority.
  • However, according to Wei, entrepreneurs and investors are not moving into deep tech because of policy or tightened regulations.
  • Its founder, Wei Zhou, is one of China's most successful venture capitalists in technology and a former managing partner at KPCB China.
  • He has been honored as Fortune's Most Influential Venture Capitalist and a Leading Chinese Venture Capitalist by the Financial Times.

LiveOak Announces Partner Promotions After the Successful Close of $210M Fund III

Retrieved on: 
Tuesday, March 15, 2022

The promotions coincide with the launch of the firms third fund, a $210M fund focused on early-stage companies in Texas.

Key Points: 
  • The promotions coincide with the launch of the firms third fund, a $210M fund focused on early-stage companies in Texas.
  • The pair join Founding Partners Venu Shamapant and Krishna Srinivasan who launched LiveOak nearly a decade ago.
  • View the full release here: https://www.businesswire.com/news/home/20220315005383/en/
    We are delighted with Mike and Creightons promotions as the new partners at LiveOak.
  • Prior to joining LiveOak in 2018, Mike spent six years with early-stage venture firm Blue Heron Capital in Virginia.

Wei Zhou from CCV, awarded 2021 China's Best Venture Capitalists by Forbes for the fifth consecutive year

Retrieved on: 
Tuesday, January 18, 2022

BEIJING, Jan. 18, 2022 /PRNewswire/ --Recently, Forbes China released its "2021 China's Best Venture Capitalists" list, and Mr. Wei Zhou, Founding Partner of CCV, was ranked in "China's Best Venture Capitalists Top 30".

Key Points: 
  • BEIJING, Jan. 18, 2022 /PRNewswire/ --Recently, Forbes China released its "2021 China's Best Venture Capitalists" list, and Mr. Wei Zhou, Founding Partner of CCV, was ranked in "China's Best Venture Capitalists Top 30".
  • This is the fifth consecutive listing since Wei Zhou founded CCV in 2017 together with his KPCB TMT team, and the award is another highlight in its fruitful season.
  • CCV portfolio Himalaya FM, the head platform of domestic audio sharing is about to land in the capital market through HKSE.
  • Focusing on digital human solutions, the leading AI deep-tech company Shukun, another portfolio under CCV, filed for its IPO in Hong Kong in Sept. 2021.